Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Alina Sturdza, Richard Pötter, Lars Ulrik Fokdal...
https://pubmed.ncbi.nlm.nih.gov/27134181Actively Recruiting
Age: 18Years - 80Years
FEMALE
ID05242861
A Retrospective Study of Brachytherapy in Gynecological Cancers
Led by Zhejiang Cancer Hospital · Updated on 2022-02-16
300
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates the use of brachytherapy for treating gynecological cancers by looking back at past treatments and outcomes. It aims to evaluate aspects such as the applicator, dose, schedule, technology, imaging methods, 3D printing, effectiveness, and side effects of brachytherapy in this patient group. The study is observational and focuses on female patients with various gynecologic cancers. Participants include females aged 18 to 80 who have previously undergone brachytherapy for gynecological cancers such as cervical, uterine, vulvar, vaginal, or ovarian cancers. The study collects data retrospectively on different types of brachytherapy treatments, including radical, adjuvant, palliative, and others related to gynecologic oncology. The interventions studied involve radiation treatment details and technology used. During the study, researchers review past patient data to measure outcomes like the 5-year overall survival rate, progression-free survival rate, and side effects experienced over five years. There is no active treatment or new intervention; instead, the study analyzes historical records to better understand brachytherapy's long-term results and safety. The study is sponsored by Zhejiang Cancer Hospital and will continue collecting data until the end of 2027.
CONDITIONS
Brief Title
Retrospective Study of Brachytherapy
Who Can Participate
Age: 18Years - 80Years
FEMALE
Eligibility Criteria
You may qualify if you...
- Female aged 18 to 80 years
- Have undergone brachytherapy treatment
- Diagnosed with a gynecological cancer
You will not qualify if you...
- Refusal to enter this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 5 years
Participants who have undergone brachytherapy are observed for overall survival, progression-free survival, and side effects over time.
Periodic visits depending on clinical follow-up
Trial Site Locations
Total: 1 location
1
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022
Actively Recruiting
Loading map...
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer.
Jacob Christian Lindegaard, Mikkel Lænsø Madsen, Anders Traberg...
https://pubmed.ncbi.nlm.nih.gov/26743833Inversely designed, 3D-printed personalized template-guided interstitial brachytherapy for vaginal tumors.
Shuhei Sekii, Kayoko Tsujino, Kengo Kosaka...
https://pubmed.ncbi.nlm.nih.gov/30479625A feasibility study for using ABS plastic and a low-cost 3D printer for patient-specific brachytherapy mould design.
Benjamin D Harris, Sanna Nilsson, Christopher M Poole
https://pubmed.ncbi.nlm.nih.gov/26108891Trends in the utilization of brachytherapy in cervical cancer in the United States.
Kathy Han, Michael Milosevic, Anthony Fyles...
https://pubmed.ncbi.nlm.nih.gov/23849695